deferoxamine has been researched along with Anemias, Iron-Deficiency in 19 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Further, there is lack of agreement about the benefits of deferoxamine (Dfx) in the treatment of anemia and oxidative stress during inflammation and chronic diseases." | 3.69 | Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine. ( Mitjavila, MT; Muntané, J; Puig-Parellada, P, 1995) |
| "Background Thrombocytopenia is common in sick neonates." | 1.46 | Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development. ( Bastian, TW; Chen, MJ; Connor, JR; Duck, KA; Georgieff, MK; Lanier, LM; Liu, ZJ; Michalopoulos, GC; Sola-Visner, MC, 2017) |
| "Iron deficiency and visceral leishmaniasis are serious problems of public health." | 1.37 | Leishmania chagasi: effect of the iron deficiency on the infection in BALB/c mice. ( Malafaia, G; Marcon, Lde N; Pedrosa, ML; Pereira, Lde F; Rezende, SA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Pietra, V | 1 |
| Degrassi, S | 1 |
| Fusi-Schmidhauser, T | 1 |
| Zhdanov, VV | 1 |
| Udut, EV | 1 |
| Sotnikova, LS | 1 |
| Burmina, YV | 1 |
| Miroshnichenko, LA | 1 |
| Simanina, EV | 1 |
| Polyakova, TY | 1 |
| Zyuz'kov, GN | 1 |
| Chaikovskii, AV | 1 |
| Stavrova, LA | 1 |
| Fedorova, EP | 1 |
| Dygai, AM | 1 |
| Usende, IL | 1 |
| Leitner, DF | 1 |
| Neely, E | 1 |
| Connor, JR | 2 |
| Olopade, JO | 1 |
| Bastian, TW | 1 |
| Duck, KA | 1 |
| Michalopoulos, GC | 1 |
| Chen, MJ | 1 |
| Liu, ZJ | 1 |
| Lanier, LM | 1 |
| Sola-Visner, MC | 1 |
| Georgieff, MK | 1 |
| Lakhal, S | 1 |
| Talbot, NP | 1 |
| Crosby, A | 1 |
| Stoepker, C | 1 |
| Townsend, AR | 1 |
| Robbins, PA | 1 |
| Pugh, CW | 1 |
| Ratcliffe, PJ | 1 |
| Mole, DR | 1 |
| Malafaia, G | 1 |
| Marcon, Lde N | 1 |
| Pereira, Lde F | 1 |
| Pedrosa, ML | 1 |
| Rezende, SA | 1 |
| Zhao, GY | 1 |
| Zhao, LP | 1 |
| He, YF | 1 |
| Li, GF | 1 |
| Gao, C | 1 |
| Li, K | 1 |
| Xu, YJ | 1 |
| Kuvibidila, SR | 2 |
| Porretta, C | 1 |
| De, BK | 1 |
| Roberts, WL | 1 |
| Fidler, MC | 1 |
| Davidsson, L | 1 |
| Walczyk, T | 1 |
| Hurrell, RF | 1 |
| RICHMOND, J | 1 |
| FIELDING, J | 1 |
| Wood, DM | 1 |
| Thomson, AH | 1 |
| Lawes, M | 1 |
| Jones, AL | 1 |
| Dargan, PI | 1 |
| Nurtjahja-Tjendraputra, E | 1 |
| Fu, D | 1 |
| Phang, JM | 1 |
| Richardson, DR | 1 |
| Muntané, J | 1 |
| Puig-Parellada, P | 1 |
| Mitjavila, MT | 1 |
| Reynolds, T | 1 |
| Mirfattahi, M | 1 |
| Lomas, G | 1 |
| Sajedianfard, J | 1 |
| Boroujeni, HM | 1 |
| Habibzadeh, F | 1 |
| Kitchens, D | 1 |
| Baliga, BS | 1 |
| Huang, JY | 1 |
| Wu, MS | 1 |
| Wu, CH | 1 |
2 trials available for deferoxamine and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Regulation of growth differentiation factor 15 expression by intracellular iron.
Topics: Adenocarcinoma; Anemia, Iron-Deficiency; Basic Helix-Loop-Helix Transcription Factors; Breast Neopla | 2009 |
Iron absorption from fish sauce and soy sauce fortified with sodium iron EDTA.
Topics: Adult; Anemia, Iron-Deficiency; Biological Availability; Deferoxamine; Diet; Edetic Acid; Female; Fe | 2003 |
17 other studies available for deferoxamine and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
The Dark Side of Iron.
Topics: Acidosis; Adolescent; Anemia, Iron-Deficiency; Deferoxamine; Drug Overdose; Female; Ferrous Compound | 2020 |
Pathogenetic Evaluation of Dysfunction in the Erythron System of Experimental Animals during Modeling of Iron Deficiency Anemia in the Gestation Period.
Topics: Anemia, Iron-Deficiency; Animals; Blood Cell Count; Bone Marrow; Deferoxamine; Erythrocytes; Erythro | 2016 |
The Deterioration Seen in Myelin Related Morphophysiology in Vanadium Exposed Rats is Partially Protected by Concurrent Iron Deficiency.
Topics: Anemia, Iron-Deficiency; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Deferoxamine; Femal | 2016 |
Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development.
Topics: Anemia, Iron-Deficiency; Animals; Benzoates; Biological Transport; Biomimetics; Blood-Brain Barrier; | 2017 |
Leishmania chagasi: effect of the iron deficiency on the infection in BALB/c mice.
Topics: Anemia, Iron-Deficiency; Animals; Cytokines; Deferoxamine; Female; Hemoglobins; Leishmania infantum; | 2011 |
A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency.
Topics: Alkaline Phosphatase; Anemia, Iron-Deficiency; Apoptosis; Calcification, Physiologic; Cell Line; Cel | 2012 |
Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells.
Topics: Anemia, Iron-Deficiency; Animals; Antigens, CD; B7-1 Antigen; B7-2 Antigen; Biomarkers; Cell Divisio | 2002 |
Performance characteristics of the Dimension RxL iron and total iron-binding capacity methods.
Topics: Anemia, Iron-Deficiency; Deferoxamine; Drug Overdose; Hemoglobins; Humans; Iron; Iron Chelating Agen | 2003 |
IRON DEFICIENCY ANAEMIA.
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Deferoxamine; Drug Therapy; Hematologic Diseas | 1964 |
DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Iron-Deficiency; Anemia, Pernicious; Deferoxami | 1965 |
Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.
Topics: Anemia, Iron-Deficiency; Chemical and Drug Induced Liver Injury; Child, Preschool; Deferoxamine; Fer | 2005 |
Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression.
Topics: Anemia, Iron-Deficiency; Animals; Cell Cycle; Cell Line, Tumor; Deferoxamine; G1 Phase; Half-Life; H | 2007 |
Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine.
Topics: Acute Disease; Anemia, Iron-Deficiency; Animals; Carrageenan; Chronic Disease; Deferoxamine; Disease | 1995 |
Desferrioxamine infusion due to heparin interference with iron assay. A paediatric problem.
Topics: Adolescent; Anemia, Iron-Deficiency; Blood Specimen Collection; Child, Preschool; Deferoxamine; Fail | 1997 |
Therapeutic values of different routes of administration of vitamin A with ferrous sulfate in treating deferoxamin-induced iron-deficiency anemia.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Deferoxamine; Ferrous Compounds; Injections, | 1999 |
In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells.
Topics: Anemia, Iron-Deficiency; Animals; Body Weight; CD3 Complex; Cell Division; Cell Membrane; Cells, Cul | 1999 |
The effect of an iron supplement on serum aluminum level and desferrioxamine mobilization test in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Anemia, Iron-Deficiency; Deferoxamine; Female; Ferritins; | 2001 |